Filter
2083
Filtered Results: 2083
Text search:
drug
market
Featured
Recommendations
169
New Publications
622
Language
Document type
No document type
1241
Studies & Reports
352
Guidelines
256
Strategic & Response Plan
89
Manuals
78
Fact sheets
30
Training Material
18
Situation Updates
8
Resource Platforms
7
Infographics
2
App
1
Online Courses
1
Countries / Regions
India
116
Global
77
Kenya
72
Ethiopia
68
Uganda
68
Nigeria
50
Western and Central Europe
47
Bangladesh
43
Liberia
42
Ghana
42
Myanmar / Burma
39
Sierra Leone
36
Malawi
36
Nepal
35
Tanzania
31
Zambia
30
South Africa
30
Africa
30
Rwanda
28
Zimbabwe
24
Philippines
23
Ukraine
22
South–East Asia Region
21
Latin America and the Carribbean
20
Cambodia
19
Namibia
19
Congo, Democratic Republic of
17
Lesotho
16
Asia
15
Eastern Europe
15
Botswana
14
Indonesia
12
Russia
12
Senegal
11
Syria
11
Brazil
10
Venezuela
10
Burkina Faso
9
Mozambique
9
Guinea
8
Cameroon
7
Thailand
7
Albania
7
USA
6
Haiti
6
Eswatini/ Swaziland
6
East and Southern Africa
6
Eastern Europe and Central Asia
6
China
5
Sudan
5
West and Central Africa
5
Middle East and North Africa
5
Vietnam
5
South Sudan
4
Germany
4
Colombia
4
Sri Lanka
4
Laos
4
Georgia
4
Lebanon
3
Benin
3
Peru
3
North Macedonia
3
Libya
3
Mexico
3
Western Pacific Region
3
Timor Leste/ East Timor
3
Tajikistan
3
Moldova
3
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Central African Republic
2
Argentina
2
Hungary
2
Chile
2
Bhutan
2
Poland
2
Iran
2
Kyrgyzstan
2
Morocco
1
Afghanistan
1
Turkey
1
Papua New Guinea
1
Serbia
1
Bolivia
1
Madagascar
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
884
Clinical Guidelines
151
Public Health
110
Women & Child Health
61
Key Resources
48
Pharmacy & Technologies
43
Capacity Building
17
Toolboxes
HIV
210
Mental Health
180
AMR
159
TB
126
Pharmacy
119
COVID-19
93
NCDs
44
NTDs
39
Planetary Health
32
Ebola
30
Conflict
28
Rapid Response
27
Global Health Education
26
Refugee
24
Caregiver
23
Disability
22
Health Financing Toolbox
21
Cholera
9
Natural Hazards
8
Polio
4
Specific Hazards
4
Social Ethics
4
Zika
1
Health Financing
1
Through public-private partnerships, the government of Rwanda can make more efficient use of public resources by targeting and meeting the needs of specific populations and thus help ensure family planning services and products will be available to all Rwandans in the long term. This report aims to ...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
Thousands of HIV-positive Venezuelans have been forced to leave the country, after facing discrimination and zero treatment options, according to UNAIDS.
Patients once received free ARV treatment under Venezuela’s National AIDS Program. In 2017, the country essentially ran out of ARVs—about 9 p...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Rappart sur les populations clés.
